Pioglitazone HCl CAS NO 112529-15-4 Inquire about Pioglitazone HCl
Tecoland supplies Pioglitazone HCl bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Pioglitazone HCl is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.
What is Pioglitazone HCl?![Pioglitazone HCl](https://tecoland.com/wp-content/uploads/2015/05/Pioglitazone-HCl-e1616801545655.png)
Pioglitazone hydrochloride is an odorless white crystalline powder that has a molecular formula of C19H20N2O3S•HCl and a molecular weight of 392.90 daltons. It is soluble in N, Ndimethylformamide, slightly soluble in anhydrous ethanol, very slightly soluble in acetone and acetonitrile, practically insoluble in water, and insoluble in ether.
What is the mode of action?
Pioglitazone acts as an agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors increases the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, pioglitazone both enhances tissue sensitivity to insulin and reduces hepatic gluconeogenesis. Thus, insulin resistance associated with type 2 diabetes mellitus is improved without an increase in insulin secretion by pancreatic ? cells.
What are the side effects?
- stomach pain, blood in your urine;
- painful urination;
- feeling short of breath, even with mild exertion;
- swelling or rapid weight gain;
- chest pain, general ill feeling;
- nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
- blurred vision;
- increased thirst or hunger, urinating more than usual; or
- pale skin, easy bruising or bleeding
How to dose Pioglitazone HCl?
The dose of pioglitazone HCl should not exceed 45 mg once daily since doses higher than 45 mg once daily have not been studied in placebo-controlled clinical studies.
Storage
Store at room temperature.
Disclaimer:
Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.